Although no clinical responses were noted, the results of this pilot study confirm that treatment with calcidiol also increases HLA-DR expression and plasma IL-12 and IFN-γ levels in HNSCC patients. The gene discussed is IFNG; the disease is head and neck squamous cell carcinoma.